News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Analyst action
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
ASPI's quarterly revenue increased to $5.1 million due to acquisitions and new segments, while its net loss from continuing operations narrowed to $34.0 million. The company completed the Renergen acquisition, diversifying into helium and LNG, and improved its liquidity, though it faces integration, regulatory, …
Jasper Therapeutics (JSPR) announced a net loss of $2.8 million for the second quarter ended June 30, 2026. The company recently acquired Kira Pharmaceuticals, raising approximately $132 million, and anticipates releasing interim data and making regulatory filings for its expanded pipeline assets in late …
Jasper Therapeutics (JSPR) reported a significantly narrowed net loss of $2.8 million in Q2 2026, down from $26.7 million in Q2 2025, largely due to lower operating expenses and substantial other income. The company also announced the completion of its acquisition of Kira Pharmaceuticals …
(RTTNews) - Jasper Therapeutics Inc. (JSPR), a clinical-stage biotechnology company focused on immune-mediated diseases, reported second quarter 2026 financial results and provided a corporate update following the completion of its acquisition of Kira Pharmaceuticals. The combined company is advancing a portfolio of clinical-stage therapies …
Jasper Therapeutics, Inc. reported a significant reduction in its net loss for the second quarter of 2026, posting $(2.8M) compared to $(26.7M) in the prior year, with diluted EPS improving to $(0.10) from $(1.74). The company, which remains pre-revenue, highlighted strategic repositioning through the …
Jasper Therapeutics (JSPR) significantly reduced its net loss in the first half of 2026 to $3.9 million from $48.0 million the previous year, primarily due to lower operating expenses and non-cash adjustments. Subsequent to the quarter, the company acquired Kira Pharmaceuticals, adding new complement-pathway …
Jasper Therapeutics announced its second quarter 2026 financial results, highlighted by the acquisition of Kira Pharmaceuticals and a successful $132 million PIPE financing. The combined company now possesses a strengthened portfolio of clinical-stage assets for immune-mediated diseases, including KP-104, briquilimab, and KP-701, with sufficient …
Needham Investment Management L.L.C., Needham Asset Management, LLC, and George A. Needham have filed an amended Schedule 13G disclosing beneficial ownership of 3,260,800 shares of Aspen Aerogels Inc. (ASPN), representing 3.9% of the outstanding common stock. All reported shares are held with shared voting …
Aspire Biopharma (NASDAQ: ASBP) reported significantly reduced net losses in the first half of 2026, dropping to $4.49 million from $17.92 million a year prior, largely due to lower stock-based compensation and financing costs. The company also substantially improved its balance sheet, moving from …
Aspire Biopharma Holdings, Inc. announced its participation in Sidoti & Company's Micro-Cap Virtual Investor Conference on August 19-20, 2026. Management will host one-on-one meetings and discuss its clinical pipeline and recent acquisition of Dura Driver Control Systems. The presentation is scheduled for August 19, …
Kaspi.kz (KSPI) reported strong revenue growth in H1 2026, reaching KZT 2.19 trillion, but net income remained flat at KZT 511 billion due to significantly increased costs and operating expenses. The company's Super App-driven financial and retail ecosystem continues to scale, but rising cost …
ASP Isotopes (ASPI) plans to expand its isotope production, radiopharmacy, and helium businesses, targeting commercial deliveries of stable isotopes by the second half of 2026. The company is developing proprietary enrichment technologies and expects its Renergen platform to begin Phase 1 helium production by …
Sharemaestro market context Trend signal active 51 weeks +1384.8%Piper Sandler has initiated coverage of Jasper Therapeutics (JSPR.US) with a Buy rating. The firm has set a price target of $2 for the company's shares.
Kaspi.kz, a Kazakhstani fintech and e-commerce operator, reported strong 2Q 2026 results with 15% year-on-year revenue growth and stable net income, driven by its Super App, new Kasper AI assistant, and e-commerce segment. The company also expanded into Türkiye by acquiring and rebranding Rabobank …
This article provides comprehensive financial data for Joint Stock Company Kaspi.kz (ADR) (KSPI), including live share price, performance metrics, fundamentals, valuation, and peer comparisons. It also details quarterly and annual profit & loss statements, cash flow, and global institutional holdings. The content aims to …
Shares of Aspen Aerogels (ASPN) dropped 25% after the company reported a significant 66% decline in Q4 revenue to $41.3 million, falling short of analyst expectations. The company also posted a net loss of $72.9 million and announced a strategic review to improve its …
Aspire Biopharma Holdings, Inc. announced its successful participation in CPHI Frankfurt, engaging in strategic discussions with global pharmaceutical companies regarding its sublingual high-dose aspirin. The company conducted numerous meetings with major industry players to explore technical collaboration and licensing opportunities for its lead product …
Barclays has maintained an "Underweight" rating for Aspen Aerogels (ASPN) but raised its price target from $4.00 to $5.00, an increase of 25%. Despite the raised target, analysts express caution due to the stock's 29.1% overvaluation compared to its GF Value™ of $4.81 and …
Image source: The Motley Fool. DATE Monday, Aug. 10, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Investor Relations - David FergusonChief Executive Officer and Co-Founder - Mikheil LomtadzeDeputy Chief Executive Officer - Tengiz MosidzeDeputy Chief Executive Officer - Yuri Didenko TAKEAWAYS Revenue -- KZT …
Search by ticker symbol or company name and select a result to open its chart.